Endothelial activation and repair during hantavirus infection: Association with disease outcome

Open Forum Infectious Diseases

Volumn 1, Issue 1, 2014, Pages

  Connolly Andersen, Anne Marie ^a   Thunberg, Therese ^a   Ahlm, Clas ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Endothelial activation; Endothelial surface layer; Endothelium; Glycocalyx; Hantavirus; Hemorrhagic fever with renal syndrome; Puumala virus; Vasculogenesis angiogenesis

Indexed keywords

ALBUMIN; ANGIOPOIETIN; CELL ADHESION MOLECULE; D DIMER; ERYTHROPOIETIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERCELLULAR ADHESION MOLECULE 1; SELECTIN; SOMATOMEDIN BINDING PROTEIN 1; STROMAL CELL DERIVED FACTOR 1; SYNDECAN 1; VASCULOTROPIN;

ADULT; ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOTHELIAL ACTIVATION; ENDOTHELIAL DYSFUNCTION; EPISTAXIS; FEMALE; FOLLOW UP; HANTAVIRUS INFECTION; HEART INFARCTION; HEMORRHAGIC FEVER WITH RENAL SYNDROME; HUMAN; HYPOXIA; IMMUNOFLUORESCENCE TEST; LEUKOCYTE ADHERENCE; MALAISE; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROTEINURIA; PUUMALA VIRUS; THROMBOCYTE COUNT; THROMBOCYTOPENIA; VASCULAR DISEASE; VASCULAR SURGERY;

EID: 84940448032     PISSN: None     EISSN: 23288957     Source Type: Journal    
DOI: 10.1093/ofid/ofu027     Document Type: Article

References (46)

1. Ye X, Ding J, Zhou X, et al. Divergent roles of endothelial NF-κB in multiple organ injury and bacterial clearance in mouse models of sepsis. J Exp Med 2008; 205:1303-15.
2. Schnittler HJ, Feldmann H. Viral hemorrhagic fever-a vascular disease? Thromb Haemost 2003; 89:967-72.
3. Vaheri A, Strandin T, Hepojoki J, et al. Uncovering the mysteries of hantavirus infections. Nat Rev Microbiol 2013; 11:539-50.
4. Rasmuson J, Andersson C, Norrman E, et al. Time to revise the paradigm of hantavirus syndromes? Hantavirus pulmonary syndrome caused by European hantavirus. Eur J Clin Microbiol Infect Dis 2011; 30:685-90.
5. Bjorkstrom NK, Lindgren T, Stoltz M, et al. Rapid expansion and longterm persistence of elevated NK cell numbers in humans infected with hantavirus. J Exp Med 2011; 208:13-21.
6. Marsac D, Garcia S, Fournet A, et al. Infection of human monocytederived dendritic cells by ANDES Hantavirus enhances proinflammatory state, the secretion of active MMP-9 and indirectly enhances endothelial permeability. Virol J 2011; 8:223.
7. Rasmuson J, Pourazar J, Linderholm M, et al. Presence of activated airway T lymphocytes in human Puumala hantavirus disease. Chest 2011; 140:715-22.
8. Shrivastava-Ranjan P, Rollin PE, Spiropoulou CF. Andes virus disrupts the endothelial cell barrier by induction of vascular endothelial growth factor and downregulation of VE-cadherin. J Virol 2010; 84:11227-34.
9. Krautkramer E, Grouls S, Stein N, et al. Pathogenic old world hantaviruses infect renal glomerular and tubular cells and induce disassembling of cell-to-cell contacts. J Virol 2011; 85:9811-23.
10. Becker BF, Chappell D, Jacob M. Endothelial glycocalyx and coronary vascular permeability: the fringe benefit. Bas Res Cardiol 2010; 105:687-701.
11. van Golen RF, van Gulik TM, Heger M. Mechanistic overview of reactive species-induced degradation of the endothelial glycocalyx during hepatic ischemia/reperfusion injury. Free Radic Biol Med 2012; 52:1382-402.
12. Becker BF, Chappell D, Bruegger D, et al. Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential. Cardiovasc Res 2010; 87:300-10.
13. Reitsma S, Slaaf DW, Vink H, et al. The endothelial glycocalyx: composition, functions, and visualization. Pflugers Arch 2007; 454:345-59.
14. Johansson PI, Stensballe J, Rasmussen LS, et al. A high admission syndecan-1 level, a marker of endothelial glycocalyx degradation, is associated with inflammation, protein C depletion, fibrinolysis, and increased mortality in trauma patients. Ann Surg 2011; 254:194-200.
15. Nelson A, Berkestedt I, Schmidtchen A, et al. Increased levels of glycosaminoglycans during septic shock: relation to mortality and the antibacterial actions of plasma. Shock 2008; 30:623-7.
16. Rehm M, Bruegger D, Christ F, et al. Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia. Circulation 2007; 116:1896-906.
17. Rabelink TJ, de Boer HC, van Zonneveld AJ. Endothelial activation and circulating markers of endothelial activation in kidney disease. Nat Rev Nephrol 2010; 6:404-14.
18. Aird WC. Endothelium in health and disease. Pharmacol Rep 2008; 60:139-43.
19. George AL, Bangalore-Prakash P, Rajoria S, et al. Endothelial progenitor cell biology in disease and tissue regeneration. J Hematol Oncol 2011; 4:24.
20. Leone AM, Valgimigli M, Giannico MB, et al. From bone marrow to the arterial wall: the ongoing tale of endothelial progenitor cells. Eur Heart J 2009; 30:890-9.
21. Gorbunova E, Gavrilovskaya IN, Mackow ER. Pathogenic hantaviruses Andes virus and Hantaan virus induce adherens junction disassembly by directing vascular endothelial cadherin internalization in human endothelial cells. J Virol 2010; 84:7405-11.
22. Taylor SL, Wahl-Jensen V, Copeland AM, et al. Endothelial cell permeability during hantavirus infection involves factor XII-dependent increased activation of the kallikrein-kinin system. PLoS Pathog 2013; 9:e1003470.
23. Potter DR, Jiang J, Damiano ER. The recovery time course of the endothelial cell glycocalyx in vivo and its implications in vitro. Circ Res 2009; 104:1318-25.
24. Sundberg E, Hultdin J, Nilsson S, et al. Evidence of disseminated intravascular coagulation in a hemorrhagic Fever with renal syndromescoring models and severe illness. PLoS One 2011; 6:e21134.
25. Takala A, Lahdevirta J, Jansson SE, et al. Systemic inflammation in hemorrhagic fever with renal syndrome correlates with hypotension and thrombocytopenia but not with renal injury. J Infect Dis 2000; 181:1964-70.
26. Rasche FM, Uhel B, Kruger DH, et al. Thrombocytopenia and acute renal failure in Puumala hantavirus infections. Emerg Infect Dis 2004; 10:1420-5.
27. Wills BA, Oragui EE, Dung NM, et al. Size and charge characteristics of the protein leak in dengue shock syndrome. J Infect Dis 2004; 190:810-8.
28. Custodio RJ, do Carmo Custodio VI, Scrideli CA, et al. Impact of hypoxia on IGF-I, IGF-II, IGFBP-3, ALS and IGFBP-1 regulation and on IGF1R gene expression in children. Growth Horm IGF Res 2012; 22:186-91.
29. Qi BT, Wang P, Li J, et al. Levels of soluble vascular cell adhesion molecule-1 and soluble intercellular adhesion molecule-2 in plasma of patients with hemorrhagic fever with renal syndrome, and significance of the changes in level. Viral Immunol 2006; 19:565-9.
30. Han Q, Zhang L, Liu Z, et al. Elevated sICAM-1 levels in patients with hemorrhagic fever with renal syndrome caused by Hantaan virus. Eur J Clin Microbiol Infect Dis 2010; 29:1507-11.
31. Temonen M, Mustonen J, Helin H, et al. Cytokines, adhesion molecules, and cellular infiltration in nephropathia epidemica kidneys: an immunohistochemical study. Clin Immunol Immunopathol 1996; 78:47-55.
32. Chappell D, Heindl B, Jacob M, et al. Sevoflurane reduces leukocyte and platelet adhesion after ischemia-reperfusion by protecting the endothelial glycocalyx. Anesthesiology 2011; 115:483-91.
33. Connolly-Andersen AM, Hammargren E, et al. Increased risk of acute myocardial infarction and stroke during hemorrhagic fever with renal syndrome: a self-controlled case series study. Circulation 2014; 129: 1295-302.
34. Salmon AH, Satchell SC. Endothelial glycocalyx dysfunction in disease: albuminuria and increased microvascular permeability. J Pathol 2012; 226:562-74.
35. Rasmuson J, Lindqvist P, Sorensen K, et al. Cardiopulmonary involvement in Puumala hantavirus infection. BMC Infect Dis 2013; 13:501.
36. Linderholm M, Groeneveld PH, Tarnvik A. Increased production of nitric oxide in patients with hemorrhagic fever with renal syndrome- relation to arterial hypotension and tumor necrosis factor. Infection 1996; 24:337-40.
37. Chappell D, Jacob M, Hofmann-Kiefer K, et al. Hydrocortisone preserves the vascular barrier by protecting the endothelial glycocalyx. Anesthesiology 2007; 107:776-84.
38. Chappell D, Westphal M, Jacob M. The impact of the glycocalyx on microcirculatory oxygen distribution in critical illness. Curr Opin Anaesthesiol 2009; 22:155-62.
39. De Backer D, Donadello K, Taccone FS, et al. Microcirculatory alterations: potential mechanisms and implications for therapy. Ann Intensive Care 2011; 1:27.
40. Ozturk B, Kuscu F, Tutuncu E, et al. Evaluation of the association of serum levels of hyaluronic acid, sICAM-1, sVCAM-1, and VEGF-A with mortality and prognosis in patients with Crimean-Congo hemorrhagic fever. J Clin Virol 2010; 47:115-9.
41. Luplertlop N, Misse D. MMP cellular responses to dengue virus infection-induced vascular leakage. Jpn J Infect Dis 2008; 61:298-301.
42. Vial PA, Valdivieso F, Ferres M, et al. High-dose intravenous methylprednisolone for hantavirus cardiopulmonary syndrome in Chile: a double-blind, randomized controlled clinical trial. Clin Infect Dis 2013; 57:943-51.
43. Jacob M, Paul O, Mehringer L, et al. Albumin augmentation improves condition of guinea pig hearts after 4 hr of cold ischemia. Transplantation 2009; 87:956-65.
44. Nguyen-Pouplin J, Pouplin T, Van TP, et al. Dextran fractional clearance studies in acute dengue infection. PLoS Negl Trop Dis 2011; 5: e1282.
45. Gavrilovskaya I, Gorbunova E, Koster F, et al. Elevated VEGF levels in pulmonary edema fluid and PBMCs from patients with acute hantavirus pulmonary syndrome. Adv Virol 2012; 2012:674360.
46. Krautkramer E, Grouls S, Hettwer D, et al. Mobilization of circulating endothelial progenitor cells (cEPCs) correlates with the clinical course of hantavirus disease. J Virol 2014; 88:483-9.